FDA Inspection 1228575 — Amgen Inc.
The FDA completed an inspection of Amgen Inc. on January 17, 2024 in New Albany, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- New Albany, OH (United States)